NEW YORK – Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo”, “the Company”) today issued an update on its ongoing litigation surrounding the protection of its intellectual property and contractual rights. Two of the cases, in which Enzo is the Plaintiff, are scheduled for jury trials. Both cases will be tried in the United States District Court […]
WALTHAM, Mass. — Thermo Fisher Scientific (NYSE:TMO), the world leader in serving science, today announced that it has signed an agreement to sell its cell culture (sera and media), gene modulation and magnetic beads businesses to GE Healthcare, a unit of General Electric Company (NYSE: GE), for approximately $1.06 billion. The businesses will become part […]
AMSBIO has expanded its portfolio of stable cell lines. The new cell lines express endogenous or recombinant proteins and are available in a ready-to-use format to facilitate your research efforts. Using AMSBIO stable cell lines not only provides an optimized solution for manufacture of therapeutic and diagnostic protein, but also for applications in drug screening, […]
NEW YORK – Enzo Biochem Inc. (NYSE:ENZ) reported today that a Federal Court Judge in New Haven, CT, in connection with the favorable November 2012 jury finding of direct infringement damages of Enzo patents by Applera Corp., now Life Technologies Inc. (NASDAQ:LIFE), has awarded the Company prejudgment interest of $12,428,729, bringing the total award to […]
CHALFONT ST. GILES, UK – GE (NYSE:GE) and Thermo Fisher Scientific (NYSE:TMO) announced today that they have entered into an agreement for GE Healthcare to acquire Thermo Fisher’s HyClone™ cell culture media and sera, and gene modulation and magnetic beads businesses for approximately $1.06 billion. The acquisition will allow GE to expand its offering of […]
MONMOUTH JUNCTION, N.J. — A requirement of massively parallel SNP analysis is to have high quality DNA suitable for target amplifications, and prepared economically from practical blood volumes. ProPrep™ Genomic is a blood DNA purification system based upon the unique protein binding reagent, ProCipitate™. Data is presented demonstrating as little as 1-2 ng of template […]
Minneapolis, Minnesota – Techne Corporation (NASDAQ: TECH) today announced that Gregory J. Melsen will resign from his position as Chief Financial Officer, effective February 3, 2014, to pursue other opportunities. Mr. Melsen has served as Techne’s Chief Financial Officer since 2004. Techne has begun the process of identifying a successor to Mr. Melsen and expects […]
AMSBIO has expanded its portfolio of stable cell lines. The new cell lines express endogenous or recombinant proteins and are available in a ready-to-use format to facilitate your research efforts. Using AMSBIO stable cell lines not only provides an optimized solution for manufacture of therapeutic and diagnostic protein, but also for applications in drug screening, […]
Porvair Sciences reports strong growing demand for their Chromatrap® chromatin immunoprecipitation (ChIP) assay technology from academic groups and biopharmaceutical organisations involved with epigenetic research. Stephen Knight, Sales and Marketing Director commented “An expanding number of proven application solutions and the introduction of the Chromatrap® 96 HT solid-state ChIP high throughput platform has enabled us to […]
Menlo Park, Calif. — DNA2.0 has entered into a research collaboration with the Infection and Immunity Research Centre at St. George’s, University of London, to support the development of plant-based biopharmaceuticals. Professor Julian Ma and his research group at St. George’s have made significant progress in the use of the tobacco plant to produce antibodies […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
